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C3 is the magic number: A simple PdII catalyst that is 
activated by a 1,4-benzoquinone (BQ) additive has been found 
to be effective for the ring-opening of arylaziridines, 
thereby providing a range of functionalized tryptamine 
derivatives. Importantly, no racemization was observed when a 
chiral aziridine starting material was used, which opens up a 
route to enantioenriched β-branched tryptamine derivatives. 
Hyland et al. (@UOW) report on #Palladium catalyzed ring-








The [PdCl2(MeCN)2]-catalyzed C3-selective Friedel--Crafts 
reaction of 2,2-disubstituted and 2-aryl-N-tosylaziridines 
with indoles is reported. For the 2,2-disubstituted 
substrates, [PdCl2(MeCN)2] alone, without any ancillary 
ligands, is an efficient catalyst for the ring-opening 
reaction. The presence of 1,4-benzoquinone as an additive was 
found to enhance the ring-opening reaction of the less-
reactive 2-arylaziridines. This reaction displayed a broad 
substrate scope with respect to the indole substrate and is 
operationally simple. Finally, when 1,3-dimethylindole was 
employed as a substrate, the de-aromatized pyrroloindoline 
product was obtained in high yield and good 
diastereoselectivity. 
Introduction 
The nucleophilic ring-opening and ring-expansion of 
aziridines is a powerful method for the synthesis of nitrogen-
containing molecules.[1] When indoles are employed as the 
nucleophile in these reactions, the resultant tryptamine ring-
opening products are particularly interesting, because they 
are found in a broad range of pharmaceutically active 
compounds and bioactive natural products.[2] Owing to the 
importance of these indole derivatives, a range of synthetic 
methods have been reported for their preparation; however, 
these methods predominantly deal with variation of the 
substituents around the indole ring, rather than branching at 
the α and β^^positions.[3] Whilst α-substituted tryptamine 
derivatives have been shown to have important biological 
activities,[4] β-branched systems, which do not occur 
naturally, have yet to be extensively explored. Tryptamines 
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are also able to undergo direct transformation into 
pyrroloindolines[5a--c] or tetrahydro-β-carbolines,[5d] as well as 
other polycyclic nitrogen-containing heterocycles; therefore, 
β-branched systems are also potential precursors of C3-
functionalized analogues of these skeletons. 
The C3-selective Lewis-acid-catalyzed ring-opening 
reaction of 2-arylaziridines with indoles is a potentially 
powerful synthetic route for the preparation of β-branched 
tryptamines (Figure^^1<figr1>). Whereas the ring-opening of 
aziridines with heteroatomic nucleophiles, such as alcohols, 
amines, thiols, and azides, is widespread,[6a--h] the Friedel--
Crafts reaction of electron-rich arenes is less well-
developed.[6i--m] In an early report, LiClO4 was shown to 
efficiently promote this reaction, but with limited substrate 
scope,[7a] whilst the use of InCl3 as a catalyst gave the 
products as a mixture of regioisomers.[7b] A dual-catalyst 
system that consisted of Sc(OTf)3/Zn(OTf)2 
(Tf=trifluoromethanesulfonyl)was used in a single example of a 
ring-opening reaction between aziridines and indoles, but the 
product was accompanied by an unidentified by-product.[7c] 
Notably, in the case of this dual catalyst, a decrease in 
enantiopurity was observed when using enantiomerically 
enriched 2-arylaziridines as the starting materials. An 
enantioselective desymmetrization of meso-aziridines with 
indoles catalyzed by MgII and a chiral quinone ligand was 
developed and used to prepare C3-halogenated 
pyrroloindolines.[5b] 
Following our completion of the work reported herein, 
three reports that detail the synthesis of tryptamine 
 4 
derivatives were published in the literature. Firstly, an 
imidazole-based zwitterionic salt that acted as an 
organocatalyst for the ring-opening reaction of 2-
arylaziridines was reported, which included several examples 
of indoles as the nucleophile.[8a] Furthermore, the ring-opening 
reactions of aziridines with indoles to afford tryptamines 
under cationic gold catalysis[8b] and the promotion of a 
stoichiometric amount of BF3<M.>OEt2 have also been 
reported.[8c] To the best of our knowledge, there are no 
examples of 2,2-disubstituted arylaziridines that undergo 
ring-opening reactions with indoles, which would lead to the 
generation of congested quaternary carbons adjacent to an 
indole.[9a--c] During the course of our recent studies on the 
PdII-catalyzed ring-opening reactions of aziridines,[10] we 
decided to investigate the use of PdII salts as Lewis acidic 
catalysts to explore the scope of the ring-opening reaction of 
aziridines with indoles. 
Herein, we report that a simple palladium salt, 
[PdCl2(MeCN)2], can catalyze the ring-opening reaction of 2-
aryl-1-tosylaziridines with a range of indoles. We have also 
found that employing 1,4-benzoquinone as an additive can 
facilitate this PdII-catalyzed process with 2-aryl-N-
tosylaziridines (Figure^^1<xfigr1>). Upon the completion of 
our investigation, we became aware of an enantiospecific PdII-
catalyzed dearomative [3<M+>2] cycloaddition reaction of 2-
arylaziridines with 2-substituted indoles[11a] and a CuI-
catalyzed kinetic resolution of 2-aryl-1-tosylaziridines with 
indoles.[11b] In contrast, the work presented herein 
demonstrates the scope of the C3-selective ring-opening 
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reaction of 2-arylaziridines with indoles to afford 
tryptamine-derivatives. 
Results and Discussion 
We initially turned our attention to the ring-opening 
reaction of 2-aryl-N-tosylaziridines, which are readily 
available from the aziridination of styrene derivatives,[12] 
with N-methylindole. First, we tested a range of Lewis acid 
catalysts in this reaction and Cu(OTf)2 (Table^^1<tabr1>, 
entry^^1) and Sc(OTf)3 (Table^^1<xtabr1>, entry^^2) both 
provided the desired product (3) in good-to-moderate yields, 
but both reactions were accompanied by an inseparable 
impurity. However, when the catalyst was switched to 
[PdCl2(MeCN)2], the reaction proceeded efficiently and, 
pleasingly, no by-product was observed (Table^^1<xtabr1>, 
entry^^3). Interestingly, the yield and conversion could be 
increased by the addition of a sub-stoichiometric amount of 
1,4-benzoquinone, which is believed to increase the π-acidity 
of the PdII catalyst (Table^^1<xtabr1>, entry^^4).[13] We found 
that changing the solvent from DCE to CHCl3 increased the yield 
further to 77^% (or 68^% without 1,4-benzoquinone; 
Table^^1<xtabr1>,  entries^^6 and 7). However, decreasing the 
loading of the [PdCl2(MeCN)2] catalyst to 5^^mol^% adversely 
effected the yield, thereby causing it to drop to 56^% without 
BQ and 58^% with BQ. 
Next, we applied our optimized conditions to the synthesis 
of a range of monosubstituted β-branched tryptamine 
derivatives (Scheme^^1<schr1>). Pleasingly, the reaction 
demonstrated excellent functional-group tolerance. Halogen 
substituents on the aziridine 2-aryl ring were successfully 
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tolerated to give the corresponding products in moderate-to-
good yields (3^c--3^e). In addition, alkyl and aryl groups, 
such as methyl and naphthalene, were also well-tolerated, and 
the corresponding products were afforded in good yields (3^b 
and 3^f). However, 2-alkyl-N-tosylaziridines, such as 7-tosyl-
7-azabicyclo[4.1.0]heptane and 2-butyl-1-tosylaziridine, were 
unreactive in the ring-opening reaction with 1-methylindole. 
We also examined a series of electron-rich indole derivatives, 
and N-benzylindole and N-allylindole reacted with aziridine 
1^a to generate the corresponding β-branched tryptamines (3^g 
and 3^h), in 60^% and 86^% yields respectively. 
Indole derivatives that contained Br, I, and F 
substituents at the C5^^position afforded the corresponding 
products (3^i, 3^j, and 3^m) in good-to-excellent yields 
(86^%, 72^%, and 60^%, respectively). Curiously, a drop in the 
yield to 50^% was observed when an indole that contained a 
methoxy group at the C5^^position was used (product 3^k). In 
addition, indoles that contained a substituent at the 
C7^^position were also tested in the reaction and, 
gratifyingly, 7-iodo-1-methylindole (2^i) gave the target 
product (3^l) in excellent yield. Interestingly, 1H-indole has 
previously been utilized to exclusively synthesize N-alkylated 
indole derivatives with vinyl aziridines under Pd0 
catalysis;[14] therefore, we were interested in examining the 
regioselectivity of the substitution reaction of 1H-indole 
with aziridine 1^a under our conditions. Pleasingly, a good 
yield and exclusive C3-regioselectivity were observed when 1H-
indole was subjected to the reaction conditions with aziridine 
1^a (product 3^n). Furthermore, when 1H-pyrrole was used as 
the nucleophile, the reaction still proceeded, but with much-
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lower yield (15^%) of the product (3^o) and with the expected 
C2^^regioselectivity. Notably, C2-substituted indoles were 
also effective substrates in the reaction; for example, 2-
phenyl-1H-indole gave the corresponding β-branched tryptamine 
(3^p) in 63^% yield with absolute C3^^regioselectivity. 
We also briefly studied the ring-opening reaction of 1-
methyl-1-phenyl-N-tosylaziridine (4) with a range of Lewis 
acids (Table^^2<tabr2>). This substrate was found to be more 
reactive than the 2-aryl-N-tosylaziridines (1), and 
[PdCl2(MeCN)2] alone was an effective catalyst for the 
preparation of tryptamine derivative 5^a in 93^% yield 
(Table^^2<xtabr2>, entry^^1). In contrast to aziridines 1, an 
excess of compound 4 was required for this reaction, likely 
owing to the competing ring-opening and elimination pathways, 
which afforded compounds 6a and 6b, respectively; thus, when 
only two equivalents of the aziridine were used, the product 
was formed in lower yield (Table^^2<xtabr2>, entry^^5). 
Sc(OTf)3 and AgSbF6 (Table^^2<xtabr2>, entries^^2 and 3) were 
poor catalysts for the reaction, but Cu(OTf)2 was found to be a 
good Lewis acid for the transformation; however, the increased 
formation of compound 6b hindered the purification of the 
products. Therefore, [PdCl2(MeCN)2] was used as the catalyst to 
evaluate the reaction scope with respect to the indole 
(Scheme^^2<schr2>). 
N-Allylindole was successfully converted into the 
corresponding product (5^b), whilst the presence of halogen 
substituents at the C5^^position of the indole was also well-
tolerated; such products (5^c--5^e) would be amenable to 
cross-coupling reactions to further increase their molecular 
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complexity. Moreover, a C5-methoxy group was found to have a 
beneficial effect on the reaction yield, by affording compound 
5^f in 85^% yield. Furthermore, we also employed 1H-indole as 
a substrate to examine the chemoselectivity of the reaction 
and complete selectivity for the C3^^product (5^g) was 
observed in a moderate yield of 56^%, with no N-substitution 
taking place. 
We also demonstrated that 1,3-dimethylindole (7) underwent 
a formal [3<M+>2] cycloaddition reaction with aziridine 1^a to 
give pyrroloindoline 8 in high yield and good 
diastereoselectivity (Scheme^^3<schr3>). In this case, a 
higher yield was obtained without the 1,4-benzoquinone 
additive, but the diastereoselectivity remained identical. The 
diastereomeric mixture of compound 8 could be readily 
detosylated with Mg/NH4Cl under ultrasound conditions to give 
compound 9, which could be isolated as the pure trans 
diastereoisomer. Upon completion of our investigation, we 
became aware of two similar syntheses of pyrroloindolines by 
using this approach: firstly by Chai et^^al., who used a 
CuI/chiral^^diphosphine catalytic system,[11b] and secondly by 
Zhao and co-workers, who used [PdCl2(PhCN)2].
[11a] 
To investigate the mechanism and stereoselectivity of the 
reaction, enantiomerically enriched aziridine (R)-1^a' was 
subjected to the Pd-catalyzed ring-opening reaction with 1-
methylindole 2a (Scheme^^4<schr4>). No significant erosion of 
enantiopurity in the ring-opened product ((R)-3^a') was 
observed when [PdCl2(MeCN)2] was used alone or with 1,4-
benzoquinone as an additive, although, as observed in our 
optimization studies, the yield of the product was higher in 
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the presence of 1,4-benzoquinone. We postulated that 1,4-
benzoquinone could act as a π-acidic ligand on the PdII center, 
thereby increasing the overall Lewis acidity of the catalyst, 
as π-acidic interactions between palladium(II) and BQ have 
been shown to be beneficial in allylic C<C->H acetoxylation 
and amination reactions.[15--16] Another possibility is that the 
PdII catalyst undergoes deactivation by reduction into Pd0 and 
aggregation to form Pd black, which was observed in reactions 
without BQ. Then, BQ may act as a ligand to stabilize the Pd0, 
so that it could be reoxidized before forming Pd black.[17] The 
isolation of an enantiomerically enriched product (3^a) 
suggested that the ring-opening reaction proceeded through 
activation of the aziridine by coordination of the PdII 
catalyst, followed by SN2 attack of the indole on activated 
aziridine 10 or 11, rather than a ring-opened intermediate. An 
SN2 pathway for the ring-opening reaction of activated 
aziridines is consistent with the seminal work of Ghorai and 
co-workers.[7c] 
Conclusion 
In conclusion, we have reported a detailed study on the 
[PdCl2(MeCN)2]-catalyzed C3-selective Friedel--Crafts reaction 
of indoles with aziridines. A series of tryptamine derivatives 
that contained a β-substituent have been prepared; furthermore, 
an all-carbon quaternary center was created in the products of 
reactions with disubstituted aziridine 4. A 1,4-benzoquinone 
additive was found to have a beneficial effect on the yields 
of reactions with the less-reactive 2-aryl-N-tosyl aziridines. 
We postulated that the 1,4-benzoquinone could act as a π-acid, 
thereby increasing the Lewis acidity of the PdII catalyst, 
 10 
although this theory needs to be investigated in future work. 
In addition to C3-substitution, a PdII-catalyzed formal [3<M+>2] 
annulation reaction with 1,3-dimethylindole (7) to give a 
pyrroloindoline was briefly investigated. 
Experimental Section 
General Considerations 
All of the reactions were performed under a nitrogen 
atmosphere in oven-dried glassware. Anhydrous solvents were 
purified by passage through a solvent-purification system 
(purification over activated alumina, a copper catalyst, 
and/or molecular sieves). Flash-grade silica gel was used for 
the column chromatography and thin-layer chromatography was 
performed on silica gel^^60 F254 aluminum-backed sheets. 
1H^^NMR and 13C{1H}^^NMR spectra were recorded in CDCl3; 
coupling constants (J) are reported in Hz; and chemical shifts 
(δ) are reported in ppm, referenced to residual solvent peaks 
(1H^^NMR) or to the solvent (13C{1H}^^NMR). The following 
abbreviations are used in the assignment of 1H^^NMR signals: 
s=singlet, d=doublet, br=broad, app=apparent, td=doublet of 
triplets, m=multiplet. Other reagents and starting materials 
were commercially available and used without further 
purification. HPLC analysis was performed by using a 
Waters^^1525 binary pump, a Waters^^486 tunable absorbance 
detector, and a Chiralpak^^AD (25^^cm×0.46^^cm) column. 
Optical rotations were measured by using a JASCO P-2000 
polarimeter in a 10^^mL cell (path length: 1^^dm) and are 
reported as [α]<broxl>D<brtr>19</broxl> (c in g/100^^mL CHCl3) at 
19^°C. 
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Synthesis and Characterization of the Substrates 
All of the aziridines were prepared according to the 
literature procedure reported by Morgan et. al.:[12] 1-tosyl-2-
phenyl aziridine (1^a),[18] 2-(p-tolyl)-1-tosylaziridine 
(1^b),[18--19] 2-(4-bromophenyl)-1-tosylaziridine (1^c),[20] 2-(2-
chlorophenyl)-1-tosylaziridine (1^d),[21-22] 2-(4-iodophenyl)-1-
tosylaziridine (1^e),  2-(naphthalen-2-yl)-1-tosylaziridine 
(1^f),[23] and 1-tosyl-2-methyl-2-phenylaziridine (4).[24] 
General Procedure for the Synthesis of Indoles 2^a, 2^d--2^i[25] 
DMSO (0.2^M) was mixed with KOH (4.0^^equiv) under 
stirring for 30^^min. Then, the corresponding indole 
(1.0^^equiv) was added and the resulting mixture was stirred 
at RT for 1^^h. Next, iodomethane (2.0^^equiv) was added 
dropwise and the mixture was stirred for a further 24^^h. The 
reaction mixture was diluted with Et2O (50^^mL) and washed with 
water (3×50^^mL). The organic phase was dried over anhydrous 
MgSO4 and concentrated under vacuum. Purification by flash 
column chromatography on silica gel (EtOAc/n-hexane, 30:70 
v/v) gave the target compounds. 
1-Methylindole (2^a): The target compound was synthesized 
according to the general procedure, with 1H-indole (5.00^^g, 
38.1^^mmol). Purification by column chromatography on silica 
gel (EtOAc/n-hexane, 30:70 v/v) gave the product as a brown 
liquid (4.75^^g, 95^% yield). 1H^^NMR (500^^MHz, CDCl3): δ=7.60 
(d, J=7.5^^Hz, 1^H), 7.25 (d, J=8.0^^Hz, 1^H), 7.19 (t, 
J=7.0^^Hz, 1^H), 7.08 (t, J=7.0^^Hz, 1^H), 6.94 (d, J=3.0^^Hz, 
1^H), 6.45 (d, J=3.0^^Hz, 1^H), 3.64^^ppm (s, 1^H). These data 
matched the literature data.[26] 
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5-Bromo-1-methylindole (2^d): The target compound was 
synthesized according to the general procedure, with 5-
bromoindole (300^^mg, 1.53^^mmol). Purification by column 
chromatography on silica gel (EtOAc/n-hexane, 30:70 v/v) gave 
the product as a yellow solid (286^^mg, 89^% yield). 1H^^NMR 
(500^^MHz, CDCl3): δ=7.74 (s, 1^H), 7.30--7.28 (m, 1^H), 7.19 
(d, J=8.0^^Hz, 1^H), 7.05 (d, J=3.0^^Hz, 1^H), 6.42 (d, 
J=3.0^^Hz, 1^H), 3.77^^ppm (s, 3^H). These data matched the 
literature data.[26] 
5-Iodo-1-methylindole (2^e): The target compound was 
synthesized according to the general procedure, with 5-
iodoindole (500^^mg, 2.06^^mmol). Purification by column 
chromatography on silica gel (EtOAc/n-hexane, 30:70 v/v) gave 
the product as a brown solid (508^^mg, 96^% yield). 1H^^NMR 
(500^^MHz, CDCl3): δ=7.95 (s, 1^H), 7.46 (d, J=9.0^^Hz, 1^H), 
7.10 (d, J=8.0^^Hz, 1^H), 7.00 (d, J=3.5^^Hz, 1^H), 6.40 (d, 
J=2.0^^Hz, 1^H), 3.77^^ppm (s, 3^H). These data matched the 
literature data.[27] 
5-Methoxy-1-methylindole (2^g): The target compound was 
synthesized according to the general procedure, with 5-
methoxyindole (500^^mg, 3.40^^mmol). Purification by column 
chromatography on silica gel (EtOAc/n-hexane, 30:70 v/v) gave 
the product as a brown solid (510^^mg, 93^% yield). 1H^^NMR 
(500^^MHz, CDCl3): δ=7.21 (d, J=9.0^^Hz, 1^H), 7.09 (d, 
J=2.0^^Hz, 1^H), 7.02 (d, J=2.5^^Hz, 1^H), 6.89 (dd, J=8.5, 
2^^Hz, 1^H), 6.40 (d, J=3.0^^Hz, 1^H), 3.85 (s, 3^H), 
3.77^^ppm (s, 3^H). These data matched the literature data.[28] 
7-Iodo-1-methylindole (2^i): The target compound was 
synthesized according to the general procedure, with 7-
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iodoindole (300^^mg, 1.24^^mmol). Purification by column 
chromatography on silica gel (EtOAc/n-hexane, 30:70 v/v) gave 
the product as a brown solid (312^^mg, 98^% yield). 1H^^NMR 
(500^^MHz, CDCl3): δ=7.66 (d, J=7.5^^Hz, 1^H), 7.56 (d, 
J=7.5^^Hz, 1^H), 7.00 (d, J=3.0^^Hz, 1^H), 7.76 (t, J=8.0^^Hz, 
1^H), 6.40 (d, J=3.0^^Hz, 1^H), 4.17^^ppm (s, 3^H).[29] 
7-Fluoro-1-methylindole (2^f): The target compound was 
synthesized according to the general procedure, with 5-
fluoroindole (300^^mg, 2.22^^mmol). Purification by column 
chromatography on silica gel (EtOAc/n-hexane, 30:70 v/v) gave 
the product as a red solid (252^^mg, 76^% yield). 1H^^NMR 
(300^^MHz, CDCl3): δ=7.28--7.19 (m, 2^H), 7.07 (d, J=3.0^^Hz, 
1^H), 6.99--6.93 (m, 1^H), 6.43 (d, J=2.4^^Hz, 1^H), 3.78^^ppm 
(s, 3^H). These data matched the literature data.[30] 
1,3-Dimethylindole (7): The target compound was 
synthesized according to the general procedure, with 3-
methylindole (1.00^^g, 7.62^^mmol). Purification by column 
chromatography on silica gel (EtOAc/n-hexane, 30:70 v/v) gave 
the product as a yellow liquid in quantitative yield. 1H^^NMR 
(500^^MHz, CDCl3): δ=7.57 (d, J=8.0^^Hz, 1^H), 7.27(t, 
J=8.5^^Hz, 1^H), 7.22 (t, J=7.0^^Hz, 1^H), 7.11 (t, J=7.0^^Hz, 
1^H), 6.82 (s, 1^H), 3.73 (s, 3^H), 2.33^^ppm (s, 3^H). These 
data matched the literature data.[26] 
Synthesis of N-Benzylindole (2^b)[25] 
Benzyl bromide (0.913^^mL, 1.31^^g, 7.68^^mmol, 
1.5^^equiv) was added to a solution of 1H-indole (600^^mg, 
5.12^^mmol, 1.0^^equiv) and KOH (0.431^^mg, 7.68^^mmol, 
1.5^^equiv) in DMF (11^^mL). The resulting mixture was stirred 
overnight, diluted with EtOAc (20^^mL), and washed with 
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distilled water (3×20^^mL). The organic phase was dried over 
anhydrous MgSO4 and concentrated under vacuum. Purification by 
column chromatography on silica gel (EtOAc/n-hexane, 30:70 
v/v) gave the product as a white solid (871^^g, 82^% yield). 
1H^^NMR (500^^MHz, CDCl3): δ=7.65 (d, J=8.0^^Hz, 1^H), 7.31--
7.25 (m, 4^H), 7.17 (t, J=7.5^^Hz, 1^H), 7.13--7.09 (m, 4^H), 
6.55 (s, 1^H), 5.33^^ppm (s, 2^H). These data matched the 
literature data.[25] 
Synthesis of N-Allylindole (2^c)[31] 
Allyl bromide (0.410^^mL, 0.573^^g, 4.70^^mmol, 
1.1^^equiv) was added to a solution of 1H-indole (500^^mg, 
4.27^^mmol, 1.0^^equiv) and NaOH (0.342^^mg, 8.54^^mmol, 
2.0^^equiv) in DMSO (11^^mL). The resulting mixture was 
stirred overnight, diluted with EtOAc (20^^mL), and washed 
with distilled water (3×20^^mL). The organic phase was dried 
over anhydrous MgSO4 and concentrated under vacuum. 
Purification by column chromatography on silica gel (EtOAc/n-
hexane, 20:80 v/v) gave the product as a white solid (457^^mg, 
68^% yield). 1H^^NMR (500^^MHz, CDCl3): δ=7.64 (t, J=7.0^^Hz, 
1^H), 7.33 (t, J=7.0^^Hz, 1^H), 7.25--7.18 (m, 1^H), 7.13--
7.19 (m, 2^H), 6.52 (d, J=4.0^^Hz, 1^H), 6.04--5.97 (m, 1^H), 
5.21 (dd, J=4.5, 6^^Hz, 1^H), 5.10 (d, J=17.0^^Hz, 1^H), 
4.74^^ppm (d, J=1.5^^Hz, 2^H). These data matched the 
literature data.[32] 
General Procedure for the Synthesis of Compounds 3^a--3^p 
Aziridine 1^a--1^f (1.0^^equiv) was added to a solution of 
indole 2^a--2^j (1.5^^equiv), [PdCl2(MeCN)2] (0.1^^equiv), and 
1,4-benzoquinone (0.3^^equiv) at RT in air. The resulting 
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mixture was stirred at RT for 21^^h, diluted with EtOAc 
(10^^mL), and washed with distilled water (3×10^^mL). The 
organic phase was dried over anhydrous MgSO4 and concentrated 
under vacuum. The crude product was purified by column 
chromatography on silica gel (EtOAc/n-hexane, 40:60 v/v) to 
give the target products. 
4-Methyl-N-(2-(1-methyl-1^H-indol-3-yl)-2-phenylethyl) 
benzenesulfonamide (3^a): The target compound was synthesized 
according to the general procedure, with aziridine 1^a 
(50.0^^mg, 0.183^^mmol) and indole 2^a. Purification by column 
chromatography on silica gel (EtOAc/n-hexane, 40:60 v/v) gave 
the product as a colorless oil (57.2^^mg, 77^% yield). 1H^^NMR 
(300^^MHz, CDCl3): δ=7.65 (d, J=8.1^^Hz, 2^H), 7.28--7.15 (m, 
10^H), 6.98 (t, J=7.8^^Hz, 1^H), 6.76 (s, 1^H), 4.38 (t, 
J=6.0^^Hz, 1^H), 4.30 (t, J=7.5^^Hz, 1^H), 3.71 (s, 3^H), 
3.66--3.50 (m, 2^H), 2.42^^ppm (s, 3^H); 13C^^NMR (125^^MHz, 
CDCl3): δ=143.4, 141.1, 137.2, 136.7, 129.7, 128.8, 127.9, 
127.2, 127.0, 126.8, 126.7, 122.0, 119.2, 119.2, 113.9, 109.4, 
47.5, 42.5, 32.8, 21.6^^ppm; IR (KBr): <Gn><Ü=>=3743, 3277, 
2364, 1741, 1551, 1482, 1424, 1370, 1317, 1213, 1157, 1095, 
1050, 915, 868, 809, 763, 703^^cm<M->1; HRMS: m/z calcd for 
C24H24N2O2SNa: 427.1456 [M<M+>Na]
<M+>; found: 427.1469. 
4-Methyl-N-(2-(1-methyl-1^H-indol-3-yl)-2-(p-
tolyl)ethyl)benzenesulfonamide (3^b): The target compound was 
synthesized according to the general procedure, with aziridine 
1^b (100^^mg, 0.348^^mmol) and indole 2^a. Purification by 
column chromatography on silica gel (EtOAc/n-hexane, 40:60 
v/v) gave the product as a colorless oil (87.4^^mg, 60^% 
yield). 1H^^NMR (300^^MHz, CDCl3): δ=7.65 (d, J=7.8^^Hz, 2^H), 
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7.28--7.19 (m, 5^H), 7.05(s, 4^H), 6.98 (t, J=7.2^^Hz, 1^H), 
6.75 (s, 1^H), 4.38 (t, J=6.0^^Hz, 1^H), 4.26 (t, J=7.2^^Hz, 
1^H), 3.71 (s, 3^H), 3.63--3.49 (m, 2^H), 2.43 (s, 3^H), 
2.29^^ppm (s, 3^H); 13C^^NMR (75^^MHz, CDCl3): δ=143.4, 142.3, 
138.0, 137.2, 136.8, 136.6, 129.7, 129.4, 127.8, 127.2, 126.7, 
121.9, 119.2, 119.1, 114.1, 109.3, 47.5, 42.1, 32.8, 21.6, 
21.0^^ppm; IR (KBr): <Gn><Ü=>=3323, 2949, 2835, 2367, 1650, 
1512, 1449, 1410, 1326, 1157, 1094, 1018, 813, 740, 660^^cm<M-




methylbenzenesulfonamide (3^c): The target compound was 
synthesized according to the general procedure, with aziridine 
1^c (100^^mg, 0.284^^mmol) and indole 2^a. Purification by 
column chromatography on silica gel (EtOAc/n-hexane, 40:60 
v/v) gave the product as a colorless liquid (86.5^^mg, 63^% 
yield). 1H^^NMR (300^^MHz, CDCl3): δ=7.63 (d, J=8.4^^Hz, 2^H), 
7.34 (d, J=8.1^^Hz, 2^H), 7.29--7.17(m, 4^H), 7.06--6.96 (m, 
4^H), 6.78 (s, 1^H), 4.55 (t, J=6.0^^Hz, 1^H), 4.28 (t, 
J=7.8^^Hz, 1^H), 3.72 (s, 3^H), 3.60--3.47 (m, 2^H), 2.43^^ppm 
(s, 3^H); 13C^^NMR (75^^MHz, CDCl3): δ=143.5, 140.4, 137.3, 
136.6, 131.7, 129.7, 129.7, 127.1, 126.7, 126.7, 122.1, 120.7, 
119.3, 119.1, 113.3, 109.5, 47.3, 42.1, 32.8, 21.6^^ppm; IR 
(KBr): <Gn><Ü=>=3276, 2933, 2360, 1636, 1560, 1486, 1424, 
1375, 1327, 1158, 1094, 1072, 1010, 813, 738, 661^^cm<M->1; 




methylbenzenesulfonamide (3^d): The target compound was 
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synthesized according to the general procedure, with aziridine 
1^d (100^^mg, 0.325^^mmol) and indole 2^a. Purification by 
column chromatography on silica gel (EtOAc/n-hexane, 40:60 
v/v) gave the product as a colorless liquid (81.3^^mg, 57^% 
yield). 1H^^NMR (300^^MHz, CDCl3): δ=7.65 (d, J=8.1^^Hz, 2^H), 
7.34--7.07 (m, 9^H), 6.99 (t, J=7.5^^Hz, 1^H), 6.87 (s, 1^H), 
4.84 (t, J=6.9^^Hz, 1^H), 4.57 (t, J=7.0^^Hz, 1^H), 3.72 (s, 
3^H), 3.57 (app^t, J=6.6^^Hz, 2^H), 2.42^^ppm (s, 3^H); 
13C^^NMR (125^^MHz, CDCl3): δ=143.4, 138.7, 137.2, 136.6, 
133.8, 129.8, 129.7, 129.0, 128.1, 127.2, 127.1, 127.0, 127.0, 
122.1, 119.2, 119.1, 112.8, 109.4, 46.2, 38.7, 32.8, 
21.5^^ppm; IR (KBr): <Gn><Ü=>=3281, 2958, 2356, 1641, 1599, 
1565, 1473, 1424, 1375, 1325, 1155, 1094, 1015, 812, 739, 706, 
658^^cm<M->1; HRMS: m/z calcd for C24H23ClN2O2SNa: 461.1066 
[M<M+>Na]<M+>; found: 461.1073. 
N-(2-(4-Iodophenyl)-2-(1-methyl-1^H-indol-3-yl)ethyl)-4-
methylbenzenesulfonamide (3^e): The target compound was 
synthesized according to the general procedure, with aziridine 
1^e (78.0^^mg, 0.195^^mmol) and indole 2^a. Purification by 
column chromatography on silica gel (EtOAc/n-hexane, 40:60 
v/v) gave the product as a colorless liquid (61.0^^mg, 59^% 
yield). 1H^^NMR (500^^MHz, CDCl3): δ=7.62 (d, J=8.5^^Hz, 2^H), 
7.53 (d, J=8.5^^Hz, 2^H), 7.26--7.17 (m, 5^H), 6.98 (t, 
J=7.5^^Hz, 1^H), 6.91 (d, J=8.5^^Hz, 2^H), 6.77 (s, 1^H), 4.55 
(t, J=6.0^^Hz, 1^H), 4.26 (t, J=7.5^^Hz, 1^H), 3.70 (s. 3^H), 
3.60--3.56 (m, 1^H), 3.51--3.47 (m, 1^H), 2.42^^ppm (s, 3^H); 
13C^^NMR (125^^MHz, CDCl3): δ=143.5, 141.0, 137.7, 137.3, 
136.7, 130.0, 129.7, 127.1, 126.7, 126.7, 122.1, 119.3, 119.1, 
113.3, 109.5, 92.3, 47.2, 42.3, 32.8, 21.6^^ppm; IR (KBr): 
<Gn><Ü=>=3289, 2936, 1701, 1648, 1484, 1328, 1327, 1325, 1159, 
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1158, 1157, 1090, 1005, 900, 811, 742, 741, 672^^cm<M->1; HRMS: 




yl)ethyl)benzenesulfonamide (3^f): The target compound was 
synthesized according to the general procedure, with aziridine 
1^f (50.0^^mg, 0.155^^mmol) and indole 2^a. Purification by 
column chromatography on silica gel (EtOAc/n-hexane, 40:60 
v/v) gave the product as a colorless liquid (55.0^^mg, 78^% 
yield). 1H^^NMR (300^^MHz, CDCl3): δ=7.78--7.85 (m, 1^H), 7.70 
(d, J=8.4^^Hz, 2^H), 7.63--7.61 (m, 3^H), 7.47--7.40 (m, 3^H), 
7.30--7.15 (m, 5^H), 6.96 (t, J=7.2^^Hz, 1^H), 6.81 (s, 1^H), 
4.52 (t, J=5.9^^Hz, 1^H), 4.47 (t, J=7.5^^Hz, 1^H), 3.78--3.70 
(m, 1^H), 3.70 (s, 3^H), 3.66--3.57 (m, 1^H), 2.41^^ppm (s, 
3^H); 13C^^NMR (75^^MHz, CDCl3): δ=143.3, 138.6, 137.3, 136.8, 
133.4, 132.5, 129.7, 128.5, 127.8, 127.6, 127.1, 126.7, 126.8, 
126.4, 126.2, 125.8, 122.0, 119.2, 114.0, 109.4, 47.4, 42.7, 
32.8, 21.5^^ppm; IR (KBr): <Gn><Ü=>=3290, 3058, 2935, 2319, 
1607, 1470, 1420, 1326, 1156, 1093, 1013, 908, 858, 813, 736, 
662^^cm<M->1; HRMS: m/z calcd for C28H26N2O2SNa: 477.1613 
[M<M+>Na]<M+>; found: 477.1616. 
N-(2-(1-Benzyl-1^H-indol-3-yl)-2-phenylethyl)-4-
methylbenzenesulfonamide (3^g): The target compound was 
synthesized according to the general procedure, with aziridine 
1^a (50.0^^mg, 0.183^^mmol) and indole 2^b. Purification by 
column chromatography on silica gel (EtOAc/n-hexane, 40:60 
v/v) gave the product as a white solid (52.8^^mg, 60^% yield). 
M.p. 130--135^°C; 1H^^NMR (300^^MHz, CDCl3): δ=7.64 (d, 
J=7.8^^Hz, 2^H), 7.34--7.06 (m, 15^H), 6.99 (t, J=7.8^^Hz, 
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1^H), 6.85 (s, 1^H), 5.25 (s, 2^H), 4.38 (t, J=5.7^^Hz, 1^H), 
4.33 (t, J=7.5^^Hz, 1^H), 3.70--3.48 (m, 2^H), 2.42^^ppm (s, 
3^H); 13C^^NMR (75^^MHz, CDCl3): δ=143.4, 141.0, 137.3, 136.9, 
136.8, 129.7, 128.8, 128.8, 128.0, 127.7, 127.1, 127.0, 126.6, 
126.0, 126.0, 122.2, 119.5, 119.4, 114.7, 109.9, 50.0, 47.5, 
42.6, 21.6^^ppm; IR (KBr): <Gn><Ü=>=3290, 3030, 2255, 1599, 
1550, 1496, 1453, 1399, 1327, 1157, 1093, 1074, 1017, 908, 
814, 730, 699, 662^^cm<M->1; HRMS: m/z calcd for C30H28N2O2SNa: 
503.1769 [M<M+>Na]<M+>; found: 503.1778. 
N-(2-(1-Allyl-1^H-indol-3-yl)-2-phenylpropyl)-4-
methylbenzenesulfonamide (3^h): The target compound was 
synthesized according to the general procedure, with aziridine 
1^a (50.0^^mg, 0.183^^mmol) and indole 2^c. The reaction was 
performed in CH2Cl2. Purification by column chromatography on 
silica gel (EtOAc/n-hexane, 40:60 v/v) gave the product as a 
colorless oil (67.9^^mg, 86^% yield). 1H^^NMR (300^^MHz, 
CDCl3): δ=7.66 (d, J=8.4^^Hz, 2^H), 7.33--7.16 (m, 10^H), 6.99 
(t, J=7.2^^Hz, 1^H), 6.82 (s, 1^H), 6.01--5.92 (m, 1^H), 5.20 
(d, J=10.2^^Hz, 1^H), 5.08 (d, J=17.1^^Hz, 1^H), 4.66 (d, 
J=5.4^^Hz, 2^H), 4.40 (t, J=6.0^^Hz, 1^H), 4.31 (t, J=7.8^^Hz, 
1^H), 3.70--3.48 (m, 2^H), 2.44^^ppm (s, 3^H); 13C^^NMR 
(75^^MHz, CDCl3): δ=143.4, 141.0, 136.8, 136.7, 133.3, 129.9, 
129.7, 128.8, 127.9, 127.1, 127.1, 127.0, 125.6, 122.0, 119.3, 
117.5, 114.4, 109.8, 48.8, 47.5, 42.6, 21.6^^ppm; IR (KBr): 
<Gn><Ü=>=3300, 3033, 2926, 1598, 1546, 1494, 1466, 1452, 1405, 
1325, 1184, 1156, 1093, 1074, 1016, 990, 909, 813, 735, 731, 
699, 663^^cm<M->1; HRMS: m/z calcd for C27H28N2O2SNa: 453.1613 
[M<M+>Na]<M+>; found: 453.1593. 
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N-(2-(5-Bromo-1-methyl-1^H-indol-3-yl)-2-phenylethyl)-4-
methylbenzenesulfonamide (3^i): The target compound was 
synthesized according to the general procedure, with aziridine 
1^a (50.0^^mg, 0.183^^mmol) and indole 2^d. Purification by 
column chromatography on silica gel (EtOAc/n-hexane, 40:60 
v/v) gave the product as a colorless oil (76.1^^mg, 86^% 
yield). 1H^^NMR (500^^MHz, CDCl3): δ=7.66 (d, J=8.5^^Hz, 2^H), 
7.30--7.22 (m, 7^H), 7.16--7.13 (m, 3^H), 6.83 (s, 1^H), 4.39 
(t, J=6.0^^Hz, 1^H), 4.19 (t, J=7.0^^Hz, 1^H), 3.71 (s, 3^H), 
3.55 (app^q, J=7.5^^Hz, 2^H), 2.46^^ppm (s, 3^H); 13C^^NMR 
(75^^MHz, CDCl3): δ=143.6, 140.7, 136.7，135.9, 129.8, 128.9, 
128.5, 127.9, 127.8, 127.2, 127.1, 124.9, 121.6, 113.6, 112.6, 
110.9, 47.4, 42.2, 33.0, 21.6^^ppm; IR (KBr): <Gn><Ü=>=3296, 
2882, 1598, 1477, 1423, 1324, 1213, 1158, 1093, 1073, 908, 
814, 793, 730, 701, 662^^cm<M->1; HRMS: m/z calcd for 
C24H24BrN2O2S: 483.0742 [M<M+>H]
<M+>; found: 483.0733. 
N-(2-(5-Iodo-1-methyl-1^H-indol-3-yl)-2-phenylethyl)-4-
methylbenzenesulfonamide (3^j): The target compound was 
synthesized according to the general procedure, with aziridine 
1^a (50.0^^mg, 0.183^^mmol) and indole 2^e. Purification by 
column chromatography on silica gel (EtOAc/ n-hexane, 40:60 
v/v) gave the product as a colorless oil (69.9^^mg, 72^% 
yield). 1H^^NMR (500^^MHz, CDCl3): δ=7.65 (d, J=8.0^^Hz, 2^H), 
7.51 (s, 1^H), 7.42 (d, J=8.0^^Hz, 1^H), 7.31--7.28 (m, 2^H), 
7.26 (d, J=8.0^^Hz, 2^H), 7.23--7.20 (m, 1^H), 7.14 (d, 
J=7.0^^Hz, 2^H), 7.03 (d, J=8.5^^Hz, 1^H), 6.77 (s, 1^H), 4.42 
(t, J=6.0^^Hz, 1^H), 4.18 (t, J=7.5^^Hz, 1^H), 3.69 (s, 3^H), 
3.53 (app^q, J=6.5^^Hz, 2^H), 2.46^^ppm (s, 3^H); 13C^^NMR 
(75^^MHz, CDCl3): δ=143.6, 140.7, 136.7, 136.3, 130.3, 129.9, 
129.4, 128.9, 127.9, 127.8, 127.6, 127.2, 127.1, 113.4, 111.4, 
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82.8, 47.5, 42.2, 32.9, 21.7^^ppm; IR (KBr): <Gn><Ü=>=3751, 
3651, 3275, 2880, 2362, 1650, 1541, 1475, 1422, 1326, 1158, 
1093, 909, 813, 792, 732, 665^^cm<M->1; HRMS: m/z calcd for 
C24H23IN2O2SNa: 553.0423 [M<M+>Na]
<M+>; found: 553.0444. 
N-(2-(5-Methoxy-1-methyl-1^H-indol-3-yl)-2-phenylethyl)-4-
methylbenzenesulfonamide (3^k): The target compound was 
synthesized according to the general procedure, with aziridine 
1^a (50.0^^mg, 0.183^^mmol) and indole 2^g. Purification by 
column chromatography on silica gel (EtOAc/n-hexane, 40:60 
v/v) gave the product as a colorless oil (39.8^^mg, 50^% 
yield). 1H^^NMR (500^^MHz, CDCl3): δ=7.65 (d, J=8.0^^Hz, 2^H), 
7.26 (d, J=7.5^^Hz, 4^H), 7.22--7.15 (m, 4^H), 6.85 (dd, 
J=8.5, 2.5^^Hz, 1^H), 6.72 (s, 1^H), 6.70 (d, J=2.0^^Hz, 1^H), 
4.40 (t, J=6.0^^Hz, 1^H), 4.28 (t, J=7.5^^Hz, 1^H), 3.72 (s, 
3^H), 3.69 (s, 3^H), 3.64--3.61 (m, 1^H), 3.54--3.50 (m, 1^H), 
2.43^^ppm (s, 3^H); 13C^^NMR (75^^MHz, CDCl3): δ=153.8, 143.4, 
141.0, 136.7, 132.1, 132.3, 129.7, 128.8, 127.9, 127.3, 127.1, 
127.0, 113.3, 112.1, 110.1, 101.0, 55.8, 47.3, 42.6, 32.9, 
21.5^^ppm; IR (KBr): <Gn><Ü=>=3281, 2938, 1623, 1599, 1491, 
1452, 1424, 1326, 1266, 1212, 1158, 1093, 1065, 1035, 815, 
794, 734, 665^^cm<M->1; HRMS: m/z calcd for C25H26N2O3SNa: 
457.1567 [M<M+>Na]<M+>; found: 457.1562. 
N-(2-(7-Iodo-1-methyl-1^H-indol-3-yl)-2-phenylethyl)-4-
methylbenzenesulfonamide (3^l): The target compound was 
synthesized according to the general procedure, with aziridine 
1^a (50.0^^mg, 0.183^^mmol) and indole 2^i. Purification by 
column chromatography on silica gel (EtOAc/n-hexane, 40:60 
v/v) gave the product as a colorless oil (73.8^^mg, 76^% 
yield). 1H^^NMR (500^^MHz, CDCl3): δ=7.65 (d, J=8.0^^Hz, 2^H), 
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7.62 (d, J=7.0^^Hz, 1^H), 7.27--7.20 (m, 6^H), 7.14 (d, 
J=7.5^^Hz, 2^H), 6.75 (s, 1^H), 6.64 (t, J=8.0^^Hz, 1^H), 4.42 
(t, J=6.0^^Hz, 1^H), 4.27 (t, J=7.5^^Hz, 1^H), 4.09 (s, 3^H), 
3.63--3.57 (m, 1^H), 3.52--3.46 (m, 1^H), 2.43^^ppm (s, 3^H); 
13C^^NMR (75^^MHz, CDCl3): δ=143.5, 140.6, 136.8, 136.0, 134.4, 
129.8, 129.7, 129.3, 128.8, 127.8, 127.2, 127.1, 120.9, 119.3, 
113.5, 73.0, 47.4, 42.1, 36.8, 21.6^^ppm; IR (KBr): 
<Gn><Ü=>=3292, 2919, 1599, 1550, 1482, 1451, 1405, 1324, 1303, 
1156, 1089, 1065, 1028, 838, 813, 737, 699, 665^^cm<M->1; HRMS: 




methylbenzenesulfonamide (3^m): The target compound was 
synthesized according to the general procedure, with aziridine 
1^a (50.0^^mg, 0.183^^mmol) and indole 2^f. Purification by 
column chromatography on silica gel (EtOAc/n-hexane, 40:60 
v/v) gave the product as a colorless oil (46.4^^mg, 60^% 
yield). 1H^^NMR (500^^MHz, CDCl3): δ=7.65 (d, J=8.0^^Hz, 2^H), 
7.29--7.14 (m, 8^H), 6.92 (td, J=9.0, 2.0^^Hz, 1^H), 6.86 (s, 
1^H), 6.79 (dd, J=9.5, 2.0^^Hz, 1^H), 4.36 (t, J=6.0^^Hz, 
1^H), 4.20 (t, J=7.5^^Hz, 1^H), 3.72 (s, 3^H), 3.58--3.52 (m, 
2^H), 2.44^^ppm (s, 3^H); 13C^^NMR (75^^MHz, CDCl3): δ=157.5 
(d, J=234^^Hz), 143.6, 140.8, 136.6, 133.9, 129.8, 128.8, 
128.3, 127.8, 127.1, 127.0, 126.9, 113.7 (d, J=4.6^^Hz), 110.4 
(d, J=26.7^^Hz), 110.1 (d, J=11.5^^Hz), 104.1 (d, J=23^^Hz), 
47.3, 42.4, 33.1, 21.5^^ppm; IR (KBr): <Gn><Ü=>=3283, 2933, 
1598, 1490, 1452, 1424, 1325, 1158, 1093, 909, 814, 794, 730, 
701, 669, 665, 659^^cm<M->1; HRMS: m/z calcd for C24H23FN2O2SNa: 
423.1543 [M<M+>Na]<M+>; found: 423.1525. 
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N-(2-(1^H-Indol-3-yl)-2-phenylethyl)-4-
methylbenzenesulfonamide (3^n): The target compound was 
synthesized according to the general procedure, with aziridine 
1^a (50.0^^mg, 0.183^^mmol) and 1H-indole. Purification by 
column chromatography on silica gel (EtOAc/n-hexane, 40:60 
v/v) gave the product as a colorless oil (54.3^^mg, 76^% 
yield). 1H^^NMR (500^^MHz, CDCl3): δ=8.06 (br^s, 1^H), 7.66 (d, 
J=8.0^^Hz, 2^H), 7.35 (d, J=7.5^^Hz, 1^H), 7.28--7.25 (m, 
5^H), 7.22 (d, J=7.0^^Hz, 1^H), 7.18--7.15 (m, 3^H), 7.00 (t, 
J=8^^Hz, 1^H), 6.97 (s, 1^H), 4.38 (t, J=6.0^^Hz, 1^H), 4.32 
(t, J=7.5^^Hz, 1^H), 3.69--3.66 (m, 1^H), 3.56--3.53 (m, 1^H), 
2.44^^ppm (s, 3^H); 13C^^NMR (75^^MHz, CDCl3): δ=143.5, 140.9, 
136.8, 136.5, 129.7, 128.8, 127.9, 127.1, 127.0, 126.4, 122.5, 
121.9, 119.7, 119.2, 115.6, 111.2, 47.4, 42.6, 21.5^^ppm; IR 
(KBr): <Gn><Ü=>=3438, 3329, 2360, 2157, 1968, 1653, 1491, 
1457, 1402, 1317, 1150, 1093, 1012, 867, 808, 755, 699, 
657^^cm<M->1; HRMS: m/z calcd for C23H22N2O2SNa: 413.1300 
[M<M+>Na]<M+>; found: 413.1286. 
4-Methyl-N-(2-phenyl-2-(1^H-pyrrol-3-
yl)ethyl)benzenesulfonamide (3^o): The target compound was 
synthesized according to the general procedure, with aziridine 
1^a (50.0^^mg, 0.183^^mmol) and 1H-pyrrole. Purification by 
column chromatography on silica gel (EtOAc/n-hexane, 40:60 
v/v) gave the product as a dark oil (9.35^^mg, 15^% yield). 
1H^^NMR (300^^MHz, CDCl3): δ=7.81 (br^s, 1^H), 7.62 (d, 
J=8.5^^Hz, 2^H), 7.24--7.16 (m, 6^H), 7.02 (d, J=7.0^^Hz, 
2^H), 6.59 (s, 1^H), 6.07 (d, J=2.5^^Hz, 1^H), 5.88 (s, 1^H), 
4.39 (t, J=6.0^^Hz, 1^H), 4.04 (t, J=7.5^^Hz, 1^H), 3.45--3.40 
(m, 1^H), 3.37--3.32 (m, 1^H), 2.37^^ppm (s, 3^H); 13C^^NMR 
(75^^MHz, CDCl3): δ=142.6, 138.8, 135.7, 129.6, 128.8, 128.0, 
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127.0, 126.5, 126.1, 116.7, 107.5, 104.7, 46.4, 43.5, 
20.5^^ppm; IR (KBr): <Gn><Ü=>=3281, 2935, 1696, 1599, 1550, 
1491, 1448, 1395, 1324, 1158, 1093, 1023, 812, 700, 658^^cm<M-




yl)ethyl)benzenesulfonamide (3^p): The target compound was 
synthesized according to the general procedure, with aziridine 
1^a (50.0^^mg, 0.183^^mmol) and 2-phenyl-1H-indole. 
Purification by column chromatography on silica gel (EtOAc/n-
hexane, 40:60 v/v) gave the product as a colorless oil 
(53.8^^mg, 63^% yield). 1H^^NMR (500^^MHz, CDCl3): δ=8.31 
(br^s, 1^H), 7.44 (d, J=8.5^^Hz, 2^H), 7.40 (d, J=8.0^^Hz, 
1^H), 7.35 (app^s, 6^H), 7.24--7.18 (m, 6^H), 7.09 (d, 
J=7.5^^Hz, 2^H), 6.93 (t, J=7.5^^Hz, 1^H), 4.44 (dd, J=11.0, 
6.0^^Hz, 1^H), 4.22 (app^d, J=8.0^^Hz, 1^H), 3.76--3.72 (m, 
1^H), 3.64 (t, J=11.0^^Hz, 1^H), 2.38^^ppm (s, 3^H); 13C^^NMR 
(75^^MHz, CDCl3): δ=143.1, 141.6, 137.7, 136.2, 136.2, 132.1, 
129.6, 128.9, 128.7, 128.7, 128.4, 127.7, 127.0, 127.0, 126.7, 
122.5, 120.2, 120.0, 111.5, 109.5, 46.7, 42.2, 21.5^^ppm; IR 
(KBr): <Gn><Ü=>=3346, 2941, 1599, 1491, 1450, 1399, 1319, 
1154, 1093, 1019, 922, 845, 813, 743, 700, 661^^cm<M->1; HRMS: 
m/z calcd for C23H22N2O2SNa: 489.1613 [M<M+>Na]
<M+>; found: 
489.1628. 
General Procedure for the Synthesis of Compounds 5^a--5^g 
A solution of 2-methyl-2-phenyl-1-tosyl aziridine (4; 
3.0^^equiv) in anhydrous DCE (30^^mL) was added dropwise over 
6^^h to a solution of N-methylindole 2^a--2^h (1.0^^equiv) in 
anhydrous DCE (10^^mL) at 0^°C under a nitrogen atmosphere. 
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The resulting mixture was stirred at 0^°C overnight, diluted 
with EtOAc (20^^mL), and washed with distilled water 
(3×20^^mL). The organic phase was dried over anhydrous MgSO4 
and concentrated under vacuum. The crude product was purified 
by column chromatography on silica gel (EtOAc/n-hexane, 40:60 
v/v) to give the product as a colorless oil. 
4-Methyl-N-(2-(1-methyl-1^H-indol-3-yl)-2-
phenylpropyl)benzenesulfonamide (5^a): The target compound was 
synthesized according to the general procedure, with aziridine 
4 (100^^mg, 0.348^^mmol) and compound 2^a (15.4^^mg, 
0.116^^mmol). Purification by column chromatography on silica 
gel (EtOAc/n-hexane, 40:60 v/v) gave the product as a 
colorless oil (45.2^^mg, 93^% yield). 1H^^NMR (500^^MHz, 
CDCl3): δ=7.49 (d, J=8.5^^Hz, 2^H), 7.28 (d, J=8.5^^Hz, 1^H), 
7.25--7.14 (m, 8^H), 7.01 (s, 1^H), 6.76--6.72 (m, 2^H), 4.03 
(dd, J=8.5, 4.5^^Hz, 1^H), 3.79 (s, 3^H), 3.65 (dd. J=11.5, 
9.0^^Hz, 1^H), 3.53 (dd, J=11.5, 4.5^^Hz, 1^H), 2.39 (s, 3^H), 
1.73^^ppm (s, 3^H); 13C^^NMR (75^^MHz, CDCl3): δ=145.7, 143.2, 
137.7, 136.1, 129.6, 128.4, 127.8, 126.9, 126.6, 126.5, 125.6, 
121.7, 120.7, 118.9, 117.8, 109.4, 51.5, 43.0, 32.9, 27.3, 
21.5^^ppm; IR (KBr): <Gn><Ü=>=3337, 2978, 2922, 1647, 1560, 
1540, 1473, 1452, 1374, 1317, 1155, 1085, 1045, 879, 663^^cm<M-




methylbenzenesulfonamide (5^b): The target compound was 
synthesized according to the general procedure, with aziridine 
4 (90.4^^mg, 0.315^^mmol) and compound 2^b (22.0^^mg, 
0.105^^mmol). Purification by column chromatography on silica 
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gel (EtOAc/n-hexane, 40:60 v/v) gave the product as a 
colorless oil (73.5^^mg, 81^% yield; 8^% of an inseparable 
compound was also produced). 1H^^NMR (500^^MHz, CDCl3): δ=7.48 
(d, J=8.5^^Hz, 2^H), 7.35--7.08 (m, 15^H), 6.76 (d, J=8.1^^Hz, 
1^H), 6.75 (s, 1^H), 5.32 (d, J=5^^Hz, 2^H) 4.00 (dd, J=7.5, 
4.0^^Hz, 1^H), 3.66 (dd, J=11.5, 8.5^^Hz, 1^H), 3.54 (dd, 
J=11.0, 4.0^^Hz, 1^H), 2.38 (s, 3^H), 1.73^^ppm (s, 3^H); 
13C^^NMR (75^^MHz, CDCl3): δ=145.5, 143.2, 137.4, 137.3, 136.1, 
129.6, 128.9, 128.5, 127.7, 127.1, 127.0, 126.9, 126.6, 126.6, 
125.9, 121.9, 120.9, 119.1, 118.8, 110.0, 51.5, 50.1, 43.1, 
27.1, 21.5^^ppm; IR (KBr): <Gn><Ü=>=3287, 3061, 2923, 1598, 
1543, 1496, 1453, 1402, 1327, 1184, 1160, 1092, 1062, 1029, 
965, 909, 814, 729, 699, 665^^cm<M->1; HRMS: m/z calcd for 
C31H30N2O2SNa: 517.1926 [M<M+>Na]
<M+>; found: 517.1951. 
N-(2-(1-Allyl-1^H-indol-3-yl)-2-phenylpropyl)-4-
methylbenzenesulfonamide (5^c): The target compound was 
synthesized according to the general procedure, with aziridine 
4 (130^^mg, 0.452^^mmol) and compound 2^c (23.7^^mg, 
0.151^^mmol). Purification by column chromatography on silica 
gel (EtOAc/n-hexane, 40:60 v/v) gave the product as a 
colorless oil (51.0^^mg, 73^% yield). 1H^^NMR (500^^MHz, 
CDCl3): δ=7.50 (d, J=8.0^^Hz, 2^H), 7.29--7.16 (m, 8^H), 7.12 
(t, J=7.5^^Hz, 1^H), 7.05 (s, 1^H), 6.78--6.72 (m, 2^H), 6.06-
-6.00 (m, 1^H), 5.25 (d, J=10.0^^Hz, 1^H), 5.14 (d, 
J=17.0^^Hz, 1^H), 4.50 (d, J=1.5^^Hz, 2^H), 4.02 (dd, J=8.0, 
4.0^^Hz, 1^H), 3.66 (dd, J=11.0, 8.0^^Hz, 1^H), 3.54 (dd, 
J=11.0, 4.0^^Hz, 1^H), 2.39 (s, 3^H), 1.73^^ppm (s, 3^H); 
13C^^NMR (75^^MHz, CDCl3): δ=145.6, 143.2, 137.2, 136.2, 133.3, 
129.6, 128.6, 128.5, 127.0, 126.6, 126.5, 125.9, 121.7, 120.8, 
119.0, 118.4, 117.6, 109.8, 51.6, 48.9, 43.1, 27.2, 21.5^^ppm; 
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IR (KBr): <Gn><Ü=>=3299, 2360, 1635. 1539, 1466, 1399, 1328, 
1186, 1161, 1093, 1061, 812, 739, 699, 663^^cm<M->1; HRMS: m/z 
calcd for C27H28N2O2Na: 467.1769 [M<M+>Na]
<M+>; found: 467.1788. 
N-(2-(5-Bromo-1-methyl-1^H-indol-3-yl)-2-phenylpropyl)-4-
methylbenzenesulfonamide (5^d): The target compound was 
synthesized according to the general procedure, with aziridine 
4 (101^^mg, 0.352^^mmol) and compound 2^d (25.0^^mg, 
0.117^^mmol). Purification by column chromatography on silica 
gel (EtOAc/n-hexane, 40:60 v/v) gave the product as a 
colorless oil (53.4^^mg, 91^% yield). 1H^^NMR (500^^MHz, 
CDCl3): δ=7.47 (d, J=8.5^^Hz, 2^H), 7.26--7.12 (m, 9^H), 7.04 
(s, 1^H), 6.80 (s, 1^H), 4.01 (dd, J=9.0, 4.0^^Hz, 1^H), 3.77 
(s, 3^H), 3.65 (dd, J=11.0, 8.5^^Hz, 1^H), 3.41 (dd, J=11.4, 
4.0, 1^H), 2.41 (s, 3^H), 1.71^^ppm (s, 3^H); 13C^^NMR 
(75^^MHz, CDCl3): δ=145.2, 143.4, 136.4, 135.8, 129.7, 129.1, 
128.6, 127.2, 126.9, 126.8, 126.5, 124.7, 122.9, 117.5, 112.4, 
111.0, 51.4, 42.9, 33.1, 27.3, 21.6^^ppm; IR (KBr): 
<Gn><Ü=>=3289, 2916, 1705, 1653, 1573, 1488, 1420, 1317, 1161, 
1093, 1060, 1029, 813, 792, 765, 700, 668^^cm<M->1; HRMS: m/z 
calcd for C25H24BrN2O2S: 495.0742 [M<M->H]
<M->; found: 495.0720. 
N-(2-(5-Iodo-1-methyl-1^H-indol-3-yl)-2-phenylpropyl)-4-
methylbenzenesulfonamide (5^e): The target compound was 
synthesized according to the general procedure, with aziridine 
4 (83.0^^mg, 0.288^^mmol) and compound 2^e (25.0^^mg, 
0.0961^^mmol). Purification by column chromatography on silica 
gel (EtOAc/n-hexane, 40:60 v/v) gave the product as a 
colorless oil (23.0^^mg, 44^% yield). 1H^^NMR (500^^MHz, 
CDCl3): δ=7.47 (d, J=8.0^^Hz, 2^H), 7.39 (d, J=8.5^^Hz, 1^H), 
7.26--7.20 (m, 5^H), 7.12 (d, J=7.5^^Hz, 2^H), 7.06 (d, 
 28 
J=8.5^^Hz, 1^H), 7.02 (m, 1^H), 6.99 (s, 1^H), 4.91--3.99 (m, 
1^H), 3.77 (s, 3^H), 3.65 (dd, J=11.0, 8.5^^Hz, 1^H), 3.41 
(dd, J=11.0, 3.5^^Hz, 1^H), 2.42 (s, 3^H), 1.71^^ppm (s, 3^H); 
13C^^NMR (75^^MHz, CDCl3): δ=145.1, 143.4, 136.8, 135.8, 130.1, 
129.8, 129.1, 128.7, 128.5, 128.0, 126.8, 126.7, 126.4, 117.2, 
111.5, 82.7, 51.4, 42.9, 33.0, 27.3, 21.7^^ppm; IR (KBr): 
<Gn><Ü=>=3272, 2973, 1701, 1636, 1542, 1471, 1418, 1330, 1160, 
1091, 895, 814, 766, 701, 666^^cm<M->1; HRMS: m/z calcd for 
C25H24IN2O2S: 543.0603 [M<M->H]
<M->; found: 543.0595. 
N-(2-(5-Fluoro-1-methyl-1^H-indol-3-yl)-2-phenylpropyl)-4-
methylbenzenesulfonamide (5^f): The target compound was 
synthesized according to the general procedure, with aziridine 
4 (143^^mg, 0.496^^mmol) and compound 2^f (25.0^^mg, 
0.165^^mmol). Purification by column chromatography on silica 
gel (EtOAc/n-hexane, 40:60 v/v) gave the product as a 
colorless oil (50.4^^mg, 70^% yield). 1H^^NMR (500^^MHz, 
CDCl3): δ=7.47 (d, J=8.0^^Hz, 2^H), 7.23--7.13 (m, 8^H), 7.07 
(s, 1^H), 6.79 (dd, J=8.5, 2.0^^Hz, 1^H), 7.27 (dd, J=10.0, 
2.0^^Hz, 1^H), 4.07--4.05 (m, 1^H), 3.77 (s, 3^H), 3.65 (dd, 
J=11.0, 8.5^^Hz, 1^H), 3.43 (dd, J=11.0, 3.5^^Hz, 1^H), 2.39 
(s, 3^H), 1.70^^ppm (s, 3^H); 13C^^NMR (75^^MHz, CDCl3): 
δ=157.0 (d, J=234^^Hz) 145.3, 143.5, 135.8, 134.4, 129.6, 
129.5, 128.5, 126.9, 126.7, 126.5, 125.7 (d, J=10^^Hz) 117.6 
(d, J=5^^Hz) 110.2 (d, J=9^^Hz) 110.0 (d, J=7^^Hz) 105.5 (d, 
J=24^^Hz), 51.3, 42.9, 33.2, 27.2, 21.5^^ppm; IR (KBr): 
<Gn><Ü=>=3272, 2984, 1700, 1653, 1496, 1490, 1448, 1416, 1325, 
1241, 1161, 1083, 1022, 886, 800, 764, 715, 665^^cm<M->1; HRMS: 





4-methylbenzenesulfonamide (5^g): The target compound was 
synthesized according to the general procedure, with aziridine 
4 (131^^mg, 0.457^^mmol) and compound 2^g (25.0^^mg, 
0.152^^mmol). Purification by column chromatography on silica 
gel (EtOAc/n-hexane, 40:60 v/v) gave the product as a 
colorless oil (58.8^^mg, 85^% yield). 1H^^NMR (300^^MHz, 
CDCl3): δ=7.46 (d, J=8.0^^Hz, 2^H), 7.25--7.13 (m, 8^H), 6.99 
(s, 1^H), 6.80 (dd, J=8.7, 2.4^^Hz, 1^H), 6.04 (d, J=2.4^^Hz, 
1^H), 4.08--4.05 (m, 1^H), 3.75 (s, 3^H), 3.63 (dd, J=10.8, 
8.4^^Hz, 1^H), 3.49 (dd, J=11.0, 3.6^^Hz, 1^H), 3.42 (s, 3^H), 
2.38 (s, 3^H), 1.71^^ppm (s, 3^H); 13C^^NMR (75^^MHz, CDCl3): 
δ=153.2, 145.7, 143.2, 136.0, 133.1, 129.5, 128.4, 128.3, 
126.9, 126.6, 126.5, 125.9, 117.1, 111.7, 110.1, 102.5, 55.3, 
51.2, 42.9, 33.0, 27.2, 21.5^^ppm; IR (KBr): <Gn><Ü=>=3263, 
2981, 1700, 1653, 1560, 1491, 1424, 1321, 1225, 1162, 1083, 
1010, 814, 715, 659^^cm<M->1; HRMS: m/z calcd for C26H27N2O3S: 
447.1718 [M<M->H]<M->; found: 447.1723. 
N-(2-(1^H-Indol-3-yl)-2-phenylpropyl)-4-
methylbenzenesulfonamide (5^h): The target compound was 
synthesized according to the general procedure, with aziridine 
4 (184^^mg, 0.640^^mmol) and 1H-indole (25.0^^mg, 
0.213^^mmol). Purification by column chromatography on silica 
gel (EtOAc/n-hexane, 40:60 v/v) gave the product as a 
colorless oil (48.3^^mg, 56^% yield). 1H^^NMR (500^^MHz, 
CDCl3): δ=8.21 (br^s, 1^H), 7.48 (d, J=8.0^^Hz, 2^H), 7.34 (d, 
J=8.5^^Hz, 1^H), 7.22--7.16 (m, 9^H), 7.10 (t, J=7.5^^Hz, 
1^H), 6.76--6.72 (m, 1^H), 4.07--4.05 (m, 1^H), 3.67 (dd, 
J=11.5, 8.5^^Hz, 1^H), 3.53 (dd, J=11.0, 4.0^^Hz, 1^H), 2.38 
(s, 3^H), 1.73^^ppm (s, 3^H); 13C^^NMR (75^^MHz, CDCl3): 
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δ=145.5, 143.2, 137.0, 136.1, 129.6, 128.5, 126.9, 126.6, 
126.6, 125.2, 123.0, 122.1, 120.6, 119.6, 119.3, 111.4, 51.5, 
43.0, 27.1, 21.5^^ppm; IR (KBr): <Gn><Ü=>=3415, 2967, 1705, 
1654, 1570, 1458, 1410, 1321, 1157, 1090, 1014, 961, 813, 742, 
700, 662^^cm<M->1; HRMS: m/z calcd for C24H23N2O2S: 403.1480 [M<M-
>H]<M->; found: 403.1496. 
Synthesis of (3^aR,8^bS)-4,8^b-dimethyl-1-phenyl-3-tosyl-
1,2,3,3^a,4,8^b-hexahydrocyclopenta[b]indole (8) 
Aziridine 1^a (125.4^^mg, 0.459^^mmol, 3.0^^equiv) was 
added to a solution of 1,3-dimethylindole (7; 22.5^^mg, 
0.153^^mmol, 1.0^^equiv) and [PdCl2(MeCN)2] (4.00^^mg, 
0.0153^^mmol, 10^^mol^%) in CHCl3 (1.5^^mL) at RT in air. The 
resulting mixture was stirred at RT for 21^^h, diluted with 
EtOAc (10^^mL), and washed with distilled water (3×10^^mL). 
The organic phase was dried over anhydrous MgSO4 and 
concentrated under vacuum. Purification by column 
chromatography on silica gel (EtOAc/n-hexane, 20/80 v/v) gave 
a mixture of trans and cis products (7.3:1.0) as a white solid 
(157^^mg, 82^% yield). M.p. 135--141^°C; 1H^^NMR (300^^MHz, 
CDCl3): δ=7.87 (d, J=8.0^^Hz, 2^H; cis), 7.83 (d, J=8.0^^Hz, 
2^H; trans), 7.39 (d, J=7.5^^Hz, 2^H; cis), 7.36 (d, 
J=7.0^^Hz, 2^H; trans), 7.26--7.21(m, 6^H; trans<M+>cis), 7.16 
(t, J=8.0^^Hz, 1^H; cis), 7.02 (t, J=8.0^^Hz; trans), 6.94--
6.93 (m, 2^H; cis), 6.83 (d, J=7.5^^Hz, 2^H; trans), 6.64 (t, 
J=7.0^^Hz, 1^H; trans), 6.53 (t, J=5.5^^Hz, 2^H; trans), 6.36 
(d, J=8.0^^Hz, 1^H; cis), 6.28 (t, J=7.5^^Hz, 1^H; trans), 
5.57 (d, J=7.5^^Hz, 1^H; trans), 5.37 (s, 1^H; trans), 5.07 
(s, 1^H; cis), 3.85--3.77 (m, 3^H; trans<M+>cis), 3.62--
3.58(m, 1^H; cis), 3.41(t, J=13.0^^Hz, 1^H; trans), 3.05 (s, 
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3^H; trans), 3.04 (s, 3^H; cis), 2.74--2.70 (m, 1^H; trans), 
2.49 (s, 3^H; trans<M+>cis), 1.27 (s, 3^H; cis), 0.49^^ppm (s, 
3^H; trans); 13C^^NMR (75^^MHz, CDCl3): δ=150.8, 143.8, 137.1, 
135.7, 132.5, 129.9, 128.8, 128.4, 127.9, 127.5, 127.3, 125.4, 
116.4, 104.9, 91.1, 56.7, 54.9, 51.2, 31.2, 25.9, 21.6^^ppm; 
IR (KBr): <Gn><Ü=>=3329, 2957, 1663, 1599, 1488, 1448, 1346, 
1291, 1161, 1091, 1022, 892, 814, 753, 700, 668, 665, 613, 
612^^cm<M->1; HRMS: m/z calcd for C25H26N2O2SNa: 441.1613 
[M<M+>Na]<M+>; found: 441.1620. 
Synthesis of (3^S,3^aS,8^aR)-3^a,8-dimethyl-3-phenyl-
1,2,3,3^a,8,8^a-hexahydropyrrolo[2,3-b]indole (9)[11a] 
A mixture of compound 8 (79^^mg, 0.189^^mmol, 1.0^^equiv), 
Mg (906^^mg, 37.8^^mmol, 200^^equiv), and NH4Cl (2.02^^g, 
37.8^^mmol, 200^^equiv) in anhydrous MeOH (10^^mL) was 
sonicated for 6^^h at 30^°C. The reaction mixture was passed 
through a short pad of silica gel (1^^cm), diluted with EtOAc 
(30^^mL), and washed with distilled water (3×20^^mL). The 
organic phase was dried over anhydrous MgSO4 and concentrated 
under vacuum. The crude product was purified by column 
chromatography on silica gel (EtOAc) to give the product as a 
colorless oily liquid (28^^mg, 56^% yield). 1H^^NMR (CDCl3, 
500^^MHz): δ=7.19--7.01 (m, 3^H), 6.99 (t, J=7.5^^Hz, 1^H), 
6.89--6.87 (m, 2^H), 6.34 (d, J=8.0^^Hz, 1^H), 6.25 (t, 
J=7.5^^Hz, 1^H), 5.72 (d, J=7.0^^Hz, 1^H), 4.70 (s, 1^H), 3.25 
(dd, J=10.0, 5.5^^Hz, 1^H), 3.18--2.11 (m, 2^H), 2.90 (s, 
3^H), 2.76 (br^s, 1^H); 1.50^^ppm (s, 3^H); 13C^^NMR (CDCl3, 
125^^MHz): δ=151.7, 138.2, 131.1, 129.1, 127.8, 127.7, 126.7, 
125.4, 116.1, 104.6, 93.2, 59.4, 56.3, 50.6, 32.4, 27.3^^ppm; 
IR (KBr): <Gn><Ü=>=2923, 1738, 1604, 1496, 1452, 1386, 1342, 
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1297, 1216, 1155, 1123, 1051, 1022, 984, 912, 810, 742, 
699^^cm<M->1; HRMS: m/z calcd for C18H21N2: 265.1705 [M<M+>H]
<M+>; 
found: 265.1714. 
Synthesis and Characterization of (R)-Phenylaziridine ((R)-
1^a')[33] 
Triethylamine (2.54^^mL, 18.2^^mmol, 2.5^^equiv) was added 
to a solution of (R)-2-phenylglycinol (1.00^^g, 7.29^^mmol, 
1.0^^eq, 99^% ee) in anhydrous CH2Cl2 (100^^mL). Aryl sulfonyl 
chloride (1.53^^g, 8.02^^mmol, 1.1^^equiv) was added as a 
single portion and the mixture was stirred at RT for 8^^h. The 
reaction was quenched with water, extracted with CH2Cl2, and 
dried over anhydrous sodium sulfate. The solvent was removed 
under vacuum to give the crude product (2.22^^g), which was 
used in the next step without further purification. The crude 
product was heated at reflux with KOH (1.28^^g, 22.9^^mmol, 
3.0^^equiv) and TsCl (1.60^^g, 8.38^^mmol, 1.1^^equiv) in THF 
(38^^mL) at 65^°C for 3^^h to afford pure (R)-2-phenyl-N-
sulfonylaziridine ((R)-1^a'; 1.91^^g, 96^% yield). The 1H^^NMR 
spectrum of compound (R)-1^a' agreed with that of compound 1^a 
and matched the literature data. 
Synthesis and Characterization of (R)-4-Methyl-N-(2-(1-methyl-
1^H-indol-3-yl)-2-phenylethyl)benzenesulfonamide ((R)-
3^a') 
The target compound was synthesized according to the 
general procedure for the synthesis of compounds 3, with 
aziridine (R)-1^a' (50.0^^mg, 0.184^^mmol). Purification by 
column chromatography on silica gel (EtOAc/n-hexane, 40:60 
v/v) gave the product as a colorless oil (55.9^^mg, 75^% 
 33 
yield). The spectroscopic data matched the data for compound 
3^a; [α]<broxl>D<brtr>19</broxl>=<M->27.37 (c=0.49 in CHCl3). 
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Scheme^^1 Substrate scope for the ring-opening reaction of 2-
aryl-N-tosylaziridines (1) with indoles 2. The reactions were 
performed in CH2Cl2. 
Scheme^^2 Substrate scope for the ring-opening reaction of 
disubstituted aziridine 4 with N-methylindoles (2). 
Scheme^^3 Cycloaddition of aziridine 1^a to 1,3-
dimethylindole 7. Ts=4-toluenesulfonyl, BQ=1,4-benzoquinone. 
Scheme^^4 Ring-opening studies on enantiomerically enriched 
aziridine (R)-1^a. 
Figure^^1 PdII-catalyzed ring-opening reaction of aziridines 
with indoles and representative bioactive tryptamine 
derivatives. Ar=aryl. 
 39 
Table^^1 Selected optimization studies for the ring-opening 
reaction of N-tosylphenylaziridine with N-
methylindole.[a]<w=1><+><forr1> 
Entry Catalyst (mol^%) Solvent T [°C] Yield [%][b] 
1 Cu(OTf)2 (10) DCE RT 73
[c] 
2 Sc(OTf)3 (10) DCE RT 40
[c] 
3 [PdCl2(MeCN)2] (10) DCE RT 62 
4 [PdCl2(MeCN)2] (10) 
<M+>BQ (30) 
DCE RT 71 
5 [PdCl2(MeCN)2] (10) CHCl3  68 
6 [PdCl2(MeCN)2] (10) 
<M+>BQ (30) 
CHCl3  77 
[a]^^Reaction conditions: aziridine 4^a (1.0^^equiv), N-
methylindole (2^a; 1.5^^equiv), 21^^h. [b]^^Yield of isolated 
compound 3^a. [c]^^The product contained inseparable 
impurities. DCE=1,2-dichloroethane. 
Table^^2 Optimization studies for the ring-opening reaction of 
aziridine 1 with indole 2^a.[a]<w=1><+><forr2> 
Entry Catalyst (10^^mol^%) Solvent T [°C] Yield [%][c] (5/
1 [PdCl2(MeCN)2] DCE 0 93<dp> (71:7:22)
2 AgSbF6 DCE 0 30<dp> (37:4:59)
3 Sc(OTf)3 DCE 0 63<dp> (49:29:22)
 40 
4 Cu(OTf)2 DCE 0 94<dp> (32:5:63)
5 [PdCl2(MeCN)2] DCE
[b] 0 66<dp> (86:1:13)
6 [PdCl2(MeCN)2] CHCl3 0 66<dp> (60:40:0)
[a]^^Reaction conditions: aziridine 1 (3^^equiv), N-
methylindole (2^a; 3^^equiv), 21^^h. [b]^^Aziridine 1 
(2^^equiv) was used. [c]^^Yield of isolated compound 3. 
[d]^^The ratio was determined from the 1H^^NMR spectrum of the 
crude reaction material. 
